A Retrospective Comparison of Docetaxel and Paclitaxel for Patients with Advanced or Recurrent Esophageal Cancer Who Previously Received Platinum-Based Chemotherapy

Publisher： Karger

E-ISSN： 1423-0232|81|3-4|237-242

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.3-4, 2011-11, pp. : 237-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How Does Inhibition of the Renin-Angiotensin System Affect the Prognosis of Advanced Gastric Cancer Patients Receiving Platinum-Based Chemotherapy?

By  

Oncology, Vol. 83, Iss. 6, 2012-10 ,pp. : 354-360

Karger

Access to resources Recommend Favorite

Editorial Comment to Maintenance monotherapy with gemcitabine after standard platinum‐based chemotherapy in patients with advanced urothelial cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 495-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintenance monotherapy with gemcitabine after standard platinum‐based chemotherapy in patients with advanced urothelial cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 490-494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Inferior Survival of Advanced Pancreatic Cancer Patients Who Received Gemcitabine-Based Chemotherapy but Did Not Participate in Clinical Trials

By  

Oncology, Vol. 81, Iss. 3-4, 2011-10 ,pp. : 143-150

Karger

Access to resources Recommend Favorite